289 related articles for article (PubMed ID: 30367884)
1. Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
Jaffe GJ; Foster CS; Pavesio CE; Paggiarino DA; Riedel GE
Ophthalmology; 2019 Apr; 126(4):601-610. PubMed ID: 30367884
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Jaffe GJ; Pavesio CE;
Ophthalmology; 2020 Oct; 127(10):1395-1404. PubMed ID: 32624244
[TBL] [Abstract][Full Text] [Related]
3. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
5. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
[TBL] [Abstract][Full Text] [Related]
7. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
Callanan DG; Jaffe GJ; Martin DF; Pearson PA; Comstock TL
Arch Ophthalmol; 2008 Sep; 126(9):1191-201. PubMed ID: 18779477
[TBL] [Abstract][Full Text] [Related]
8. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
[TBL] [Abstract][Full Text] [Related]
10. The 0.2-μg/day Fluocinolone Acetonide Intravitreal Implant in Chronic Noninfectious Posterior Uveitis: A 3-year Randomized Trial in India.
Biswas J; Tyagi M; Agarwal M;
Ophthalmol Sci; 2024; 4(1):100403. PubMed ID: 38027419
[TBL] [Abstract][Full Text] [Related]
11. Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
Cai CX; Skalak C; Keenan RT; Grewal DS; Jaffe GJ
Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):1023-1030. PubMed ID: 32114654
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
13. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
Jaffe GJ
Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
[TBL] [Abstract][Full Text] [Related]
14. IOP Elevation in Patients Treated With Fluocinolone Acetonide Insert for Chronic Noninfectious Uveitis Affecting the Posterior Segment.
Singer MA; Krambeer C; Paggiarino D
Ophthalmic Surg Lasers Imaging Retina; 2021 Jul; 52(7):387-390. PubMed ID: 34309426
[TBL] [Abstract][Full Text] [Related]
15. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.
Oh EK; Lee EK; Yu HG
Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774
[TBL] [Abstract][Full Text] [Related]
17. Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Campochiaro PA; Brown DM; Pearson A; Chen S; Boyer D; Ruiz-Moreno J; Garretson B; Gupta A; Hariprasad SM; Bailey C; Reichel E; Soubrane G; Kapik B; Billman K; Kane FE; Green K;
Ophthalmology; 2012 Oct; 119(10):2125-32. PubMed ID: 22727177
[TBL] [Abstract][Full Text] [Related]
18. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.
Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group
Ophthalmology; 2015 Oct; 122(10):1976-86. PubMed ID: 26298718
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.
Testi I; Pavesio C
Ther Deliv; 2019 Oct; 10(10):621-625. PubMed ID: 31663454
[TBL] [Abstract][Full Text] [Related]
20. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
